Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Van Hul

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Frontiers in Endocrinology|April 25, 2020
WNT Signaling and Bone: Lessons From Skeletal Dysplasias and DisordersYentl Huybrechts, Geert Mortier, Eveline Boudin, et al.
Seminars in Arthritis and Rheumatism|February 26, 2013
The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseasesEveline Boudin, Igor Fijalkowski, Elke Piters, et al.
International Journal of Molecular Sciences|November 27, 2025
The Paraoxonase (<i>PON</i>) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other DiseasesTammy Huybrechts, Kristien Franck, Ellen Steenackers, et al.
Frontiers in Endocrinology|April 18, 2022
Editorial: Innovative Models in Bone Biology: What can be Learned From Rare Bone Diseases?Teun J de Vries, Wim Van Hul, E Marelise Eekhoff
European Journal of Human Genetics : EJHG|May 30, 2003
Clinical and molecular analysis of nine families with Adams-Oliver syndromePieter Verdyck, Muriel Holder-Espinasse, Wim Van Hul, et al.
Calcified Tissue International|February 6, 2019
Camurati-Engelmann DiseaseWim Van Hul, Eveline Boudin, Filip M Vanhoenacker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2004
LRP5 and Wnt signaling: a union made for boneMark L Johnson, Kimberley Harnish, Roel Nusse, et al.
Current Osteoporosis Reports|April 16, 2018
Human Genetics of Sclerosing Bone DisordersRaphaël De Ridder, Eveline Boudin, Geert Mortier, et al.
Endocrine Reviews|May 20, 2005
Transforming growth factor-beta1 to the boneKatrien Janssens, Peter ten Dijke, Sophie Janssens, et al.
Clinical Dysmorphology|September 13, 2012
Negative mutation screening of the NOG, BMPR1B, GDF5, and FGF9 genes indicates further genetic heterogeneity of the facioaudiosymphalangism syndromeJenneke J van den Ende, Vere Borra, Wim Van Hul
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Endocrinology|April 25, 2020
WNT Signaling and Bone: Lessons From Skeletal Dysplasias and DisordersYentl Huybrechts, Geert Mortier, Eveline Boudin, et al.
Seminars in Arthritis and Rheumatism|February 26, 2013
The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseasesEveline Boudin, Igor Fijalkowski, Elke Piters, et al.
International Journal of Molecular Sciences|November 27, 2025
The Paraoxonase (<i>PON</i>) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other DiseasesTammy Huybrechts, Kristien Franck, Ellen Steenackers, et al.
Frontiers in Endocrinology|April 18, 2022
Editorial: Innovative Models in Bone Biology: What can be Learned From Rare Bone Diseases?Teun J de Vries, Wim Van Hul, E Marelise Eekhoff
European Journal of Human Genetics : EJHG|May 30, 2003
Clinical and molecular analysis of nine families with Adams-Oliver syndromePieter Verdyck, Muriel Holder-Espinasse, Wim Van Hul, et al.
Calcified Tissue International|February 6, 2019
Camurati-Engelmann DiseaseWim Van Hul, Eveline Boudin, Filip M Vanhoenacker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2004
LRP5 and Wnt signaling: a union made for boneMark L Johnson, Kimberley Harnish, Roel Nusse, et al.
Current Osteoporosis Reports|April 16, 2018
Human Genetics of Sclerosing Bone DisordersRaphaël De Ridder, Eveline Boudin, Geert Mortier, et al.
Endocrine Reviews|May 20, 2005
Transforming growth factor-beta1 to the boneKatrien Janssens, Peter ten Dijke, Sophie Janssens, et al.
Clinical Dysmorphology|September 13, 2012
Negative mutation screening of the NOG, BMPR1B, GDF5, and FGF9 genes indicates further genetic heterogeneity of the facioaudiosymphalangism syndromeJenneke J van den Ende, Vere Borra, Wim Van Hul
Pageof 17